Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate |
1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a06d6f42ad74828b9a5134b9ee0641a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1df910d53e0c94833fcb401f7a231e64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd0d79baf3a1990d0b6e0c1356ca16a8 |
publicationDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2148599-C |
titleOfInvention |
Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
abstract |
The present invention relates to a stably co-transfected eukaryotic cell line capable of expressing an N-methyl-D-aspartate (NMDA) receptor, particularly a human NMDA receptor, which receptor comprises at least one R1 subunit isoform, or at least one R1 subunit isoform and one or two R2 subunits; to the cloning of novel cDNA sequences encoding the human NMDA R2A subunit and various isoforms of the human NMDA R1 subunit; and to the use of the cell line in designing and developing NMDA receptor subtype-selective medicaments. |
priorityDate |
1992-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |